Item Type | Name |
Academic Article
|
MGMT promoter methylation is predictive of response to radiotherapy and prognostic in the absence of adjuvant alkylating chemotherapy for glioblastoma.
|
Academic Article
|
Discovering functional modules by identifying recurrent and mutually exclusive mutational patterns in tumors.
|
Academic Article
|
Epidermal growth factor receptor variant III status defines clinically distinct subtypes of glioblastoma.
|
Concept
|
Glioblastoma
|
Academic Article
|
Mesenchymal differentiation mediated by NF-?B promotes radiation resistance in glioblastoma.
|
Academic Article
|
Two mature products of MIR-491 coordinate to suppress key cancer hallmarks in glioblastoma.
|
Academic Article
|
Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma.
|
Academic Article
|
A survey of intragenic breakpoints in glioblastoma identifies a distinct subset associated with poor survival.
|
Academic Article
|
Acquired resistance to anti-VEGF therapy in glioblastoma is associated with a mesenchymal transition.
|
Academic Article
|
Bevacizumab for newly diagnosed glioblastoma.
|
Academic Article
|
A multigene predictor of outcome in glioblastoma.
|
Academic Article
|
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.
|
Academic Article
|
A randomized trial of bevacizumab for newly diagnosed glioblastoma.
|
Academic Article
|
Mir-21-Sox2 Axis Delineates Glioblastoma Subtypes with Prognostic Impact.
|
Academic Article
|
Delineation of MGMT Hypermethylation as a Biomarker for Veliparib-Mediated Temozolomide-Sensitizing Therapy of Glioblastoma.
|
Academic Article
|
A Dexamethasone-regulated Gene Signature Is Prognostic for Poor Survival in Glioblastoma Patients.
|
Academic Article
|
Epigenetic Activation of WNT5A Drives Glioblastoma Stem Cell Differentiation and Invasive Growth.
|
Academic Article
|
Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotype.
|
Academic Article
|
Mir-21-Sox2 axis delineates glioblastoma subtypes with prognostic impact
|
Academic Article
|
A regulatory circuit of miR-125b/miR-20b and Wnt signalling controls glioblastoma phenotypes through FZD6-modulated pathways
|
Academic Article
|
Delineation of MGMT Hypermethylation as a Biomarker for Veliparib-Mediated Temozolomide-Sensitizing Therapy of Glioblastoma
|
Academic Article
|
A randomized trial of bevacizumab for newly diagnosed glioblastoma
|
Academic Article
|
A Dexamethasone-regulated Gene Signature Is Prognostic for Poor Survival in Glioblastoma Patients
|
Academic Article
|
Epigenetic Activation of WNT5A Drives Glioblastoma Stem Cell Differentiation and Invasive Growth
|
Academic Article
|
Dexamethasone-mediated oncogenicity in vitro and in an animal model of glioblastoma.
|
Academic Article
|
Radiation Therapy for Glioblastoma: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Guideline.
|
Academic Article
|
A regulatory circuit of miR-125b/miR-20b and Wnt signalling controls glioblastoma phenotypes through FZD6-modulated pathways.
|
Academic Article
|
Efficacy and safety results of ABT-414 in combination with radiation and temozolomide in newly diagnosed glioblastoma.
|
Academic Article
|
Radiation Therapy for Glioblastoma: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Guideline.
|
Academic Article
|
Combination therapy with potent PI3K and MAPK inhibitors overcomes adaptive kinome resistance to single agents in preclinical models of glioblastoma.
|
Academic Article
|
MerTK as a therapeutic target in glioblastoma.
|
Academic Article
|
m6A Demethylase ALKBH5 Maintains Tumorigenicity of Glioblastoma Stem-like Cells by Sustaining FOXM1 Expression and Cell Proliferation Program.
|
Academic Article
|
An independently validated nomogram for individualized estimation of survival among patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825.
|
Academic Article
|
PAF promotes stemness and radioresistance of glioma stem cells.
|
Academic Article
|
MST4 Phosphorylation of ATG4B Regulates Autophagic Activity, Tumorigenicity, and Radioresistance in Glioblastoma.
|
Academic Article
|
CDK4/6 inhibition is more active against the glioblastoma proneural subtype.
|
Academic Article
|
Targeting the mesenchymal subtype in glioblastoma and other cancers via inhibition of diacylglycerol kinase alpha.
|
Academic Article
|
A relative increase in circulating platelets following chemoradiation predicts for poor survival of patients with glioblastoma.
|
Academic Article
|
GPR56/ADGRG1 Inhibits Mesenchymal Differentiation and Radioresistance in Glioblastoma.
|
Academic Article
|
Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment.
|
Academic Article
|
Glioblastoma stem cell-derived exosomes induce M2 macrophages and PD-L1 expression on human monocytes.
|
Academic Article
|
A Coclinical Radiogenomic Validation Study: Conserved Magnetic Resonance Radiomic Appearance of Periostin-Expressing Glioblastoma in Patients and Xenograft Models.
|
Academic Article
|
Phase 1 lead-in to a phase 2 factorial study of temozolomide plus memantine, mefloquine, and metformin as postradiation adjuvant therapy for newly diagnosed glioblastoma.
|
Academic Article
|
MIR93 (microRNA -93) regulates tumorigenicity and therapy response of glioblastoma by targeting autophagy.
|
Academic Article
|
High-Throughput Automated Single-Cell Imaging Analysis Reveals Dynamics of Glioblastoma Stem Cell Population During State Transition.
|
Academic Article
|
Identification of patient-derived glioblastoma stem cell (GSC) lines with the alternative lengthening of telomeres phenotype.
|
Academic Article
|
Molecular profiling of long-term IDH-wildtype glioblastoma survivors.
|
Academic Article
|
MicroRNA-29a inhibits glioblastoma stem cells and tumor growth by regulating the PDGF pathway.
|
Academic Article
|
Genomic and Phenotypic Characterization of a Broad Panel of Patient-Derived Xenografts Reflects the Diversity of Glioblastoma.
|
Academic Article
|
EGFR Amplification Induces Increased DNA Damage Response and Renders Selective Sensitivity to Talazoparib (PARP Inhibitor) in Glioblastoma.
|
Academic Article
|
Novel Therapies for Glioblastoma.
|
Academic Article
|
A cancer drug atlas enables synergistic targeting of independent drug vulnerabilities.
|
Academic Article
|
Racial and socioeconomic disparities differentially affect overall and cause-specific survival in glioblastoma.
|
Academic Article
|
Genetic driver mutations introduced in identical cell-of-origin in murine glioblastoma reveal distinct immune landscapes but similar response to checkpoint blockade.
|
Academic Article
|
Proton therapy reduces the likelihood of high-grade radiation-induced lymphopenia in glioblastoma patients: phase II randomized study of protons vs photons.
|
Academic Article
|
Transcriptional regulatory networks of tumor-associated macrophages that drive malignancy in mesenchymal glioblastoma.
|
Academic Article
|
Dissecting the immunosuppressive tumor microenvironments in Glioblastoma-on-a-Chip for optimized PD-1 immunotherapy.
|
Academic Article
|
PRMT6 methylation of RCC1 regulates mitosis, tumorigenicity, and radiation response of glioblastoma stem cells.
|
Academic Article
|
A prospective phase II randomized trial of proton radiotherapy vs intensity-modulated radiotherapy for patients with newly diagnosed glioblastoma.
|
Academic Article
|
A randomized phase II trial of veliparib, radiotherapy, and temozolomide in patients with unmethylated MGMT glioblastoma: the VERTU study.
|
Academic Article
|
Medium-Chain Acyl-CoA Dehydrogenase Protects Mitochondria from Lipid Peroxidation in Glioblastoma.
|
Academic Article
|
Glioblastoma Clinical Trials: Current Landscape and Opportunities for Improvement.
|
Academic Article
|
Intrinsic Interferon Signaling Regulates the Cell Death and Mesenchymal Phenotype of Glioblastoma Stem Cells.
|
Academic Article
|
Stereotactic radiosurgery for glioblastoma considering tumor genetic profiles: an international multicenter study.
|
Academic Article
|
Stereotactic radiosurgery for IDH wild type glioblastoma: an international, multicenter study.
|
Academic Article
|
Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: A phase III randomized clinical trial.
|
Academic Article
|
PDPN marks a subset of aggressive and radiation-resistant glioblastoma cells.
|
Academic Article
|
Association of hyperglycemia and molecular subclass on survival in IDH-wildtype glioblastoma.
|
Academic Article
|
Germline polymorphisms in MGMT associated with temozolomide-related myelotoxicity risk in patients with glioblastoma treated on NRG Oncology/RTOG 0825.
|
Academic Article
|
Comparison of pharmacological inhibitors of lysine-specific demethylase 1 in glioblastoma stem cells reveals inhibitor-specific efficacy profiles.
|